View More Recent Stories

Feb 21, 2025 12:52PM Moderna (MRNA) Strength tied to Speculation About New Coronavirus
Jan 28, 2025 11:00AM Moderna stock rises following RFK Jr's comments
Jan 7, 2025 01:12PM Novavax (NVAX) call put ratio 8.1 calls to 1 put as share price up 12.8%
Dec 13, 2024 08:00AM Novavax (NVAX) Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50M Milestone
Dec 11, 2024 07:22AM H.C. Wainwright Reiterates Buy Rating on Novavax (NVAX)
Dec 10, 2024 08:03AM Novavax (NVAX) Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza
Dec 4, 2024 06:03AM Novavax (NVAX) Sells Czech Republic Manufacturing Site to Novo Nordisk for $200M
Nov 22, 2024 12:22PM Moderna (MRNA) +9% as Jefferies says the market is nearing short term 'peak RFK negativity'
Nov 18, 2024 07:40AM Novavax (NVAX) PT Lowered to $22 at B.Riley
Nov 13, 2024 07:59AM H.C. Wainwright Reiterates Buy Rating on Novavax (NVAX)
Nov 12, 2024 08:13AM Novavax (NVAX) Tops Q3 EPS by 7c ; Offers Guidance
Nov 11, 2024 08:30AM Novavax (NVAX) Announces FDA Removed Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
Nov 5, 2024 10:37AM Increasing unusual put option volume: BEN XLB AEM RACE EMB NXPI LYB ADM NVAX MSTX CME HIMS AUG
Oct 16, 2024 02:25PM Novavax (NVAX) October 11 calls and October 14 calls active as share price down 19%
Oct 16, 2024 01:29PM Novavax (NVAX) PT Lowered to $25 at Jefferies
Oct 16, 2024 11:43AM Novavax (NVAX) PT Lowered to $14 at BofA Securities 'to reflect delays in phase 3 CIC/standalone flu trial'
Oct 16, 2024 08:10AM Novavax (NVAX): FDA placed clinical hold on IND for COVID-19-Influenza combination and stand-alone influenza vaccine candidates
Oct 14, 2024 01:30PM Novavax (NVAX) call put ratio 14.4 calls to 1 put with focus on 23K contracts of October 35 calls
Oct 10, 2024 07:38AM Novavax (NVAX) PT Raised to $26 at B.Riley
Oct 9, 2024 07:01AM Novavax's (NVAX) Updated 2024-2025 Nuvaxovid COVID-19 Vaccine Receives Authorization in the EU
Oct 2, 2024 03:13PM Novavax (NVAX) + 22% on bullish comments at Jefferies
Sep 25, 2024 08:04AM Novavax (NVAX) Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development
Sep 13, 2024 09:26AM Novavax (NVAX) 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S.
Aug 30, 2024 03:47PM Novavax (NVAX) 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
Aug 30, 2024 02:28PM FDA Authorizes Updated Novavax (NVAX) COVID-19 Vaccine to Better Protect Against Currently Circulating Variants
Aug 8, 2024 08:57AM Novavax (NVAX) shares tumble as Q2 results miss estimates, guidance cut
Aug 8, 2024 08:04AM Novavax (NVAX) Reports Q2, Issues Operational Update
Jul 30, 2024 08:15AM Novavax shares slide as JPMorgan cuts the stock to Underweight on overvaluation concerns
Jul 30, 2024 01:53AM JPMorgan Downgrades Novavax (NVAX) to Underweight
Jul 19, 2024 11:33AM Novavax (NVAX) PT Lowered to $31 at Jefferies ahead of Q2
Jul 2, 2024 08:32AM Novavax (NVAX) Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
Jun 24, 2024 09:19AM Novavax (NVAX) Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
Jun 14, 2024 02:06PM Novavax (NVAX) Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
View More Recent Stories